FOLH1 and prostate carcinoma: In one of the largest evaluations of a retrospective study including 2533 patients with recurrent prostate cancer after prostatectomy, Afshar-Oromieh reported on a very promising performance of 68 Ga-PSMA-11 PET/CT.